Journals / Journal of Surgery and Medicine / 2018 / Cilt: 2 - Sayı: 2

Molecular mechanisms affecting estrogen receptor levels in breast cancer

Meme kanserinde östrojen reseptör seviyelerini etkileyen moleküler mekanizmalar

Pages
137–142
Publication Date
2018-05-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Increasing the number of these studies, are very significant for developing new methods of estrogen-dependent cancers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The initiation of breast cancer, estrogen and its receptor (ER) perform significant functions.
📊
Key Findings & Data:ER has two dissimilar forms, and they are commonly called as ER-alpha (-α) and ER-beta (-β).
💡
Conclusion & Impact:Increasing the number of these studies, are very significant for developing new methods of estrogen-dependent cancers.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Meme kanseri · Östrojen reseptörleri · Progesteron reseptörü

Abstract

The initiation of breast cancer, estrogen and its receptor (ER) perform significant functions. ER has two dissimilar forms, and they are commonly called as ER-alpha (-α) and ER-beta (-β). ERs are transcription factors. Expressions of ER-alpha (-α) protein are mainly arranged by the pathway of ubiquitin-proteasome. The hormone-responsive gene expression modulated by ER-α in addition to other nuclear receptors is a complicated process, which involves various cellular responses. And also, ER-α levels are related with the pathology and etiology of breast cancer. In this review which is about the transcription and expression of the ER-α gene may provide the find out biochemical mechanisms behind the breast carcinogenesis. The regulation of ER expression, histone-modifying enzymes, Progesterone receptor (PR), peroxisome proliferator-activated receptors (PPAR), hydrocarbon receptor (AhR), Glucocorticoid receptor (GR), hypoxia and lysine residuals in ER region described in detail in this work. Increasing the number of these studies, are very significant for developing new methods of estrogen-dependent cancers.

Özet

Meme kanserinin tetiklenmesinde, östrojen ve reseptörünün (ER) önemli işlevleri bulunmaktadır. ER'nin iki farklı şekli yer almakta ve bunlar ER-alfa (-α) ve ER-beta (-β) olarak adlandırılmaktadır. ER'ler birer transkripsiyon faktörüdür. ER-alfa (-α) proteininin ifadeleri esas olarak ubikuitin-proteazom yolağı ile düzenlenmektedir. Diğer nükleer reseptörlere ek olarak ER-alfa tarafından modüle edilen hormona duyarlı gen ekspresyonu, çeşitli hücresel tepkimeleri içeren karmaşık bir moleküler süreçtir. Ayrıca ER-α düzeyleri, meme kanseri patolojisi ve etyolojisi ile de ilişkilendirilmektedir. ER-α geninin transkripsiyonu ve ekspresyonu ile ilgili olan bu derleme yoluyla meme karsinojenezinin alt yapısında yer alan biyokimyasal mekanizmaların daha net anlaşılabileceği düşünülmektedir. ER ekspresyonu, histon değiştirici enzimler, Progesteron reseptörü (PR), peroksizom proliferatörü ile aktive edilmiş reseptörler (PPAR), aril-hidrokarbon reseptörü (AhR), Glukokortikoid reseptörü (GR), hipoksi ve ER bölgesinde yer alan lizinin kalıntılarının regülasyonu bu derlemede detaylı bir biçimde anlatılmaktadır. Buna benzer çalışmaların sayısının artırılması, östrojen bağımlı kanserler için yeni yöntemlerin geliştirilmesi açısından oldukça önemlidir.

🔖

Cite This Article

OKAT, Z. (2018). Molecular mechanisms affecting estrogen receptor levels in breast cancer. Journal of Surgery and Medicine, Cilt: 2 - Sayı: 2, 137–142. https://ajindex.com/articles/780751

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, Rochefort H: Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res. 2001;61(6):2537-41. PMID: 11289127
  2. Hayashi SI, Eguchi H, Tanimoto K, Yoshida T, Omoto Y, Inoue A, Yoshida N, et al. The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application. Endocr Relat Cancer. 2003;10(2):193-202. PMID: 12790782
  3. Berger SL. An embarrassment of niches: the many covalent modifications of histones in transcriptional regulation. Oncogene. 2001;20(24):3007-13. DOI: 10.1038/sj.onc.1204324 4. Lin HY, Chen CS, Lin SP, Weng JR, Chen CS. Targeting histone deacetylase in cancer therapy. Med Res Rev. 2006;26(4):397-413. DOI: 10.1002/med.20056
  4. Fukuda H, Sano N, Muto S, Horikoshi M. Simple histone acetylation plays a complex role in the regulation of gene expression. Brief Funct Genomic Proteomic. 2006;5(3):190-208. DOI: 10.1093/bfgp/ell032
  5. Tan J, Cang S, Ma Y, Petrillo RL, Liu D. Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. Journal of Hematology & Oncology. 2010;3:5. doi: 10.1186/1756-8722-3-5
  6. Bieliauskas AV, Pflum MK. Isoform-selective histone deacetylase inhibitors. Chem Soc Rev. 2008;37(7):1402-13. doi: 10.1039/b703830p
  7. Watts CK, Sweeney KJ, Warlters A, Musgrove EA, Sutherland RL. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells. Breast Cancer Res Treat. 1994;31(1):95–105. PMID: 7981461
  8. Herber B, Truss M, Beato M, Müller R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene. 1994;9(4):1295-304. PMID: 8134134
  9. Musgrove EA, Hamilton JA, Lee CS, Sweeney KJ, Watts CK, Sutherland RL. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol. 1993;13(6):3577–87. PMID: 8497271 PMCID: PMC359827
  10. Wilcken NR, Prall OW, Musgrove EA, Sutherland RL. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth inhibitory effects of antiestrogens. Clin Cancer Res. 1997;3(6):849–54. PMID: 9815758
  11. Bartkova J, Lukas J, Müller H, Lützhoft D, Strauss M, Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer. 1994;57(3):353–61. PMID: 8168995
  12. Yoshida M, Horinouchi S, Beppu T. Trichostatin A and trapoxin